As a biotechnology company, our mission is to deliver novel solutions with the highest quality standards

We strive to provide plant-based products that are both safe and effective

We are a biotechnology company that delivers high-quality and safe plant-based medicinal products and by-products from cannabis and other botanicals. We use advanced production technology and a modern and flexible business model to ensure that our products are standardized, certified, efficient, and affordable.

The overwhelming number of cannabis strains available in the market, combined with the lack of rigorous scientific research, makes it difficult for patients and companies to make informed decisions about the products they use. Bluedot provides answers to critical questions that distinguish average from outstanding medical cannabis products. Our scientific approach identifies:

With our expert insights, individuals and companies can make informed decisions about medical cannabis products, ultimately leading to better health outcomes.

We understand your product needs and regulatory and therapeutic requiretments. Our goal is to source/provide you an homogeneous and standarized product, with the discipline required to ensure compliance, continuity and scalability.

We are 100% licensed in Colombia across the entire value chain for the production and commercialization of medical cannabis, in local and international markets.

We believe ”the future of medical cannabis is varietal”, that is why we have pre-registered with the local regulator, the largest genetics bank in the Colombia (+2560 varieties).

We created a proprietary experimemtal scientific model to efficiently link strains with specific therapeutic effects, and curated class “A” genteics for 7 specific patologies.

Our cultivation, procesing and manufacturing is made at GACP, GMP and GLP facilities, under strict pharma/food grade protocoles to comply with demanding local and international regulations.

We are passionate about science and innovation, we developed a disruptive & sustainable business model to better serve patients.

We are 100% licensed in Colombia across the entire value chain for the production and commercialization of medical cannabis, in local and international markets.

We believe ”the future of medical cannabis is varietal”, that is why we have pre-registered with the local regulator, the largest genetics bank in Colombia (+2560 varieties).

We created a proprietary experimemtal scientific model to efficiently link strains with specific therapeutic effects, and curated class “A” genteics for specific patologies.

Our cultivation, procesing and manufacturing is made at GACP, GMP and GLP facilities, under strict pharma/food grade protocoles to comply with demanding local and international regulations.

We are passionate about science and innovation, we developed a disruptive & sustainable business model to better serve patients.

+ 0

cannabis strains available on demand

Our strain portfolio has been carefully studied, pre-screened, and selected to provide the best results in patients’ lives. We are committed to delivering high-quality products that can help improve your quality of life.

The future of medicinal cannabis is varietal. Different strains of cannabis contain various levels of cannabinoids, terpenes, and other compounds that may have particular therapeutic effects depending on the ratios of their compounds. For example, some strains may be particularly effective at reducing pain or inflammation, while others may be better for treating anxiety or depression. Additionally, some strains may be more appropriate for certain patient populations.

Therapeutic Potential

Medical cannabis offers a therapeutic potential for the treatments of several pathologies.

Each varietal and by-product in our portfolio have been researched, vetted, and linked to therapeutic effects within the most common ailments treated with medical cannabis.

We are not a typical cannabis company

We source and deliver high-quality, standardized, and certified products in three distinctive lines, all available in one place.

Our Smart Dry Flower/Flos portfolio offers curated medicinal strains of standardized and certified high/low THC/CBD cannabis.

Our APIs and byproducts line is designed for companies in the pharmaceutical, food & beverages, wellness, and cosmetics industries who are interested in expanding their current offering to the cannabis-derived products segment.

Our magisterial prescriptions and phytomedicines line is designed for doctors and medical institutions interested in alternative, personalized, and affordable treatment options for their patients. We use medical cannabis in our products to provide these options.